symbol,price,beta,volAvg,mktCap,lastDiv,range,changes,companyName,currency,cik,isin,cusip,exchange,exchangeShortName,industry,website,description,ceo,sector,country,fullTimeEmployees,phone,address,city,state,zip,dcfDiff,dcf,image,ipoDate,defaultImage,isEtf,isActivelyTrading,isAdr,isFund
SLDX,0.1,-2.570342,391,3446,0,0.05-0.16,-0.0421,Stella Diagnostics Inc.,USD,0001827620,,,Other OTC,PNK,Diagnostics & Research,https://www.stelladx.com,"Stella Diagnostics, Inc., a molecular diagnostics-based company, focuses on enhancing patient management strategies for people living with severe esophageal diseases. Its clinical assays offer physicians insight into the molecular properties of patients' tissue to determine if the disease is stable, progressing, or turning cancerous. The company is also developing diagnostic tools that provides molecular information for providers as compared to the screening protocols. The company was formerly known as JMP Properties, Inc. and changed its name to Stella Diagnostics, Inc. in April 2021. Stella Diagnostics, Inc. is based in Salt Lake City, Utah.",Mr. David B. Seaburg,Healthcare,US,,561 265 3272,50 West Broadway,Salt Lake City,UT,84104,,0,https://financialmodelingprep.com/image-stock/SLDX.png,2021-04-16,True,False,False,False,False
